There were no stock-based compensation expenses related to the 2013 Plan in the three and six months ended June 30, 2026 and 2025. Total stock-based compensation expense related to the 2017 Plan was as follows:


	Three Months Ended June 30,
	2026						2025
	Options		RSUs		Total		Options		RSUs		Total
Cost of revenue	$	96	$	1,057	$	1,153	$	210	$	961	$	1,171
Selling, general and administrative expense		89		8,376		8,465		253		9,410		9,663
Total	$	185	$	9,433	$	9,618	$	463	$	10,371	$	10,834

	Six Months Ended June 30,
	2026						2025
	Options		RSUs		Total		Options		RSUs		Total
Cost of revenue	$	224	$	1,834	$	2,058	$	399	$	3,043	$	3,442
Selling, general and administrative expense		240		16,393		16,633		503		20,612		21,115
Total	$	464	$	18,227	$	18,691	$	902	$	23,655	$	24,557

As of June 30, 2026 and June 30, 2025, there was $43.6 million and $65.1 million, respectively, of total unrecognized stock-based compensation expense related to unvested options and restricted stock under the 2017 Plan. Such unrecognized expense is expected to be recognized over a weighted-average 2.1 year period.

RSAs and RSUs activity was as follows:


	Six Months Ended June 30,
	2026					2025
	Shares			Weighted-Average Grant Date Fair Value		Shares			Weighted-Average Grant Date Fair Value
Beginning outstanding shares		2,324,404					2,617,059
Granted		732,868		$	25.90		1,298,765		$	17.65
Forfeited/ cancelled		(119,062	)	$	24.90		(59,042	)	$	28.85
Vested		(270,593	)	$	29.85		(597,665	)	$	26.80
Ending outstanding shares		2,667,617					3,259,117

The following summarizes the options activity of the 2017 Plan:


	Options to Purchase Common Stock			Weighted-Average Exercise Price per Share		Weighted Average Grant Date Fair Value per Share		Weighted Average Remaining Contract Life (in Years)		Aggregate Intrinsic Value of In-The-Money Options
Outstanding as of December 31, 2024		2,345,207		$	30.62	$	16.32		6.0	$	776
Forfeited/ cancelled		(35,795	)		41.32		—		—		—
Expired		(50,150	)		36.06		—		—		—
Outstanding as of June 30, 2025		2,259,262		$	30.33	$	16.32		5.5	$	4,355
Outstanding as of December 31, 2025		2,193,528		$	30.33		16.32		4.9		6,109
Forfeited/ cancelled		(6,175	)		36.88		—		—		—
Expired		(47,334	)		38.60		—		—		—
Exercised		(32,511	)		18.23		—		—		300
Outstanding as of June 30, 2026		2,107,508		$	30.31	$	16.32		4.5	$	3,048
Exercisable as of June 30, 2026		1,998,215		$	29.99				4.4	$	3,048

The following summarizes the activity of the 2013 Plan:


	Options to Purchase Common Stock			Weighted-Average Exercise Price per Share		Weighted Average Grant Date Fair Value per Share		Weighted Average Remaining Contract Life (in Years)		Aggregate Intrinsic Value of In-The-Money Options
Outstanding as of December 31, 2024		680,889		$	6.49	$	2.51		1.5	$	8,211
Expired		(1,000	)		6.03		—		—		—
Exercised		(8,895	)		8.59		—		—		10,351
Outstanding as of June 30, 2025		670,994		$	6.46	$	2.51		1.0	$	10,351
Outstanding as of December 31, 2025		567,827		$	6.51		2.51		0.5		10,401
Expired		(425	)		6.03		—		—		—
Exercised		(504,902	)		6.11		—		—		8,608
Outstanding as of June 30, 2026		62,500		$	9.76	$	2.51		0.5	$	653
Exercisable as of June 30, 2026		62,500		$	9.76				0.5	$	653

Common Stock Reserved for Future Issuances—The Company has reserved certain stock of its authorized but unissued common stock for possible future issuance in connection with the following:


	June 30,
	2026		2025
2013 Plan		62,500		670,994
2017 Plan(1)		8,011,562		7,421,326
		8,074,062		8,092,320

(1) In January 2026 and 2025, the Board of Directors ratified the addition of 1,436,436 and 1,372,373 shares of common stock, respectively, to the number of shares available for issuance under the 2017 Plan pursuant to the annual increase provision of such plan. Unless the Board of Directors determines otherwise, additional annual increases will be effective on each January 1, through January 1, 2027. The 2017 Plan permits the company to settle awards, if and when vested, in cash at its discretion. Pursuant to the terms of the 2017 Plan, the number of shares authorized for issuance thereunder will only be reduced with respect to shares of common stock actually issued upon exercise or settlement of an award. Shares of common stock subject to awards that have been canceled, expired, forfeited or otherwise not issued under an award and shares of common stock subject to awards settled in cash do not count as shares of common stock issued under the 2017 Plan. The Company expects to have sufficient shares available under the 2017 Plan to satisfy the future settlement of outstanding awards.